Cardlytics Research And Ddevelopement To Revenue from 2010 to 2025
| CDLX Stock | USD 1.17 0.00 0.00% |
Research And Ddevelopement To Revenue | First Reported 2010-12-31 | Previous Quarter 0.17825137 | Current Value 0.1 | Quarterly Volatility 0.03486243 |
Check Cardlytics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cardlytics' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 3.3 M or Depreciation And Amortization of 18.2 M, as well as many indicators such as Price To Sales Ratio of 0.61, Dividend Yield of 0.0 or PTB Ratio of 3.67. Cardlytics financial statements analysis is a perfect complement when working with Cardlytics Valuation or Volatility modules.
Cardlytics | Research And Ddevelopement To Revenue | Build AI portfolio with Cardlytics Stock |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Cardlytics Stock Analysis
When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.